Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Snynf save search
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Published: 2024-03-31 (Crawled : 00:00) - globenewswire.com
CUBT | $0.0269 -42.11% 21K
|
n/a
|
| O: 3.57%
H: 0.0%
C: -6.9%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.97%
H: 0.0%
C: 0.0%
Global Infectious Enteritis Treatment Market Report 2024: A USD$937.7 Million Market by 2034 - Antibiotics Segment Dominates the Market
Published: 2024-03-29 (Crawled : 23:00) - prnewswire.com
ARDX | News | $6.44 -1.68% -1.63% 2.9M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
report million treatment antibiotics global market
FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
fda hepatitis kidney anemia
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
| Email alert
Add to watchlist
GILD | News | $66.16 -1.15% -1.16% 4.9M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
| Email alert
Add to watchlist
GMAB | $28.33 -0.7% -0.74% 220K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $281.02 3.83% 210
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-29 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
ADAG | $2.64 4.35% -0.37% 1.8K
|
Manufacturing
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
year update financial results
Biopharma Layoff Tracker 2024: Xilio, Bayer, BMS and More Cut Staff
Published: 2024-03-28 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
RLYB | $1.67 -5.11% -4.76% 270K
|
|
| O: 0.63%
H: 16.25%
C: 15.63%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: 3.1%
H: 6.02%
C: -2.26%
TXMD | $1.89 4.55% 5.7K
|
Health Technology
|
| O: -0.88%
H: 2.21%
C: 1.33%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: 0.14%
H: 1.19%
C: -1.32%
NKTR | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: -0.58%
H: 6.82%
C: 6.16%
MOR | $18.02 -0.11% -0.11% 590K
|
Health Technology
|
| O: 0.06%
H: 0.06%
C: -0.06%
GLPG | $28.9 -1.1% -1.11% 140K
|
Health Technology
|
| O: -2.34%
H: 0.09%
C: 0.06%
AMRN | $0.8799 -4.06% -4.23% 1M
|
Health Technology
|
| O: -1.03%
H: 3.41%
C: 1.23%
GOOGL | News S | $155.97 0.32% 0.32% 19M
|
Technology Services
|
| O: -0.01%
H: 0.38%
C: 0.05%
GOOG | News S | $157.46 0.37% 0.39% 12M
|
Technology Services
|
| O: 0.04%
H: 0.44%
C: 0.17%
OCX J | $2.52 -2.7% -2.78% 37K
|
Health Technology
|
| O: 0.0%
H: 2.44%
C: -0.34%
biopharma
Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy
Published: 2024-03-28 (Crawled : 12:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
wegovy
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
Published: 2024-03-28 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
DRIO | $1.145 -5.37% -5.68% 96K
|
Health Technology
|
| O: -4.61%
H: 14.48%
C: 5.52%
financial results
Inventiva announces the nomination of Andre Turenne as Director
Published: 2024-03-28 (Crawled : 07:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
IVA | $3.28 1.86% 1.83% 12K
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: -3.47%
United States Self-Monitoring Blood Glucose Devices Market Research 2023-2032: SMBG Devices and CGM Systems Surge - The Shift from Traditional Blood Glucose Meters
Published: 2024-03-28 (Crawled : 02:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
blood research market
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.89%
H: 0.78%
C: 0.78%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.36%
H: 0.72%
C: 0.61%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.12%
H: 0.25%
C: -0.63%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
abbvie set canada key market
Biopharma Layoff Tracker 2024: Bayer, BMS, Theratechnologies and More Cut Staff
Published: 2024-03-27 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
RLYB | $1.67 -5.11% -4.76% 270K
|
|
| O: 2.72%
H: 6.62%
C: 5.3%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: 0.0%
H: 7.38%
C: 5.74%
TXMD | $1.89 4.55% 5.7K
|
Health Technology
|
| O: 0.44%
H: 0.88%
C: 0.88%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: 0.79%
H: 5.75%
C: 4.47%
NKTR | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: -2.22%
H: 4.55%
C: 0.58%
MOR | $18.02 -0.11% -0.11% 590K
|
Health Technology
|
| O: -0.11%
H: 0.08%
C: -0.11%
GLPG | $28.9 -1.1% -1.11% 140K
|
Health Technology
|
| O: -0.21%
H: 1.1%
C: 0.95%
AMRN | $0.8799 -4.06% -4.23% 1M
|
Health Technology
|
| O: 0.96%
H: 4.54%
C: 1.7%
GOOGL | News S | $155.97 0.32% 0.32% 19M
|
Technology Services
|
| O: 0.29%
H: 0.34%
C: -0.15%
GOOG | News S | $157.46 0.37% 0.39% 12M
|
Technology Services
|
| O: 0.23%
H: 0.42%
C: -0.07%
OCX J | $2.52 -2.7% -2.78% 37K
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: -1.67%
biopharma
FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.84%
H: 1.48%
C: 1.29%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
fda rare
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: Glo...
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
copd potential market
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData
Published: 2024-03-27 (Crawled : 12:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
copd potential market
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
vaccine trials
XORTX Announces New Clinical Advisory Board Member - March 27, 2024
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
XRTX | $3.5 -3.05% -3.14% 12K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.0%
C: -5.79%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
XORTX Announces New Clinical Advisory Board Member
Published: 2024-03-27 (Crawled : 09:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
XRTX | $3.5 -3.05% -3.14% 12K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.0%
C: -5.79%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - HMST, FREE, EVBG, INBX
Published: 2024-03-26 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
TGAN | $4.81 0.21% 0.21% 140K
|
Manufacturing
|
| O: 0.2%
H: 0.0%
C: -0.2%
FREE | $4.83 0.21% 0.21% 310K
|
Consumer Non-Durables
|
| O: 0.0%
H: 0.21%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
INBX | $34.47 -0.41% -0.41% 420K
|
Health Technology
|
| O: 0.29%
H: 0.23%
C: -0.06%
HMST | $12.22 -0.89% -0.57% 65K
|
Finance
|
| O: 0.26%
H: 0.07%
C: -0.85%
EVBG | $34.885 0.01% 0.01% 720K
|
Technology Services
|
| O: 0.09%
H: 0.03%
C: -0.03%
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
Published: 2024-03-27 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.5M
|
Health Technology
|
| O: -0.09%
H: 1.42%
C: 1.1%
ibi310 first cancer colon therapy study
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.